$GPRO
GoPro, Inc.

2024 Q3 Form 10-Q Financial Statement

#000150043524000154 Filed on November 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q3
Revenue $258.9M
YoY Change -12.03%
Cost Of Revenue $167.1M
YoY Change -16.51%
Gross Profit $91.85M
YoY Change -2.5%
Gross Profit Margin 35.48%
Selling, General & Admin $55.53M
YoY Change -1.34%
% of Gross Profit 60.46%
Research & Development $44.33M
YoY Change 6.28%
% of Gross Profit 48.26%
Depreciation & Amortization $1.827M
YoY Change 30.5%
% of Gross Profit 1.99%
Operating Expenses $99.86M
YoY Change 1.9%
Operating Profit -$8.011M
YoY Change 111.54%
Interest Expense $808.0K
YoY Change -31.0%
% of Operating Profit
Other Income/Expense, Net $1.883M
YoY Change 137.75%
Pretax Income -$6.100M
YoY Change 103.33%
Income Tax $2.100M
% Of Pretax Income
Net Earnings -$8.211M
YoY Change 122.88%
Net Earnings / Revenue -3.17%
Basic Earnings Per Share -$0.05
Diluted Earnings Per Share -$0.05
COMMON SHARES
Basic Shares Outstanding 153.7M shares
Diluted Shares Outstanding 153.7M shares

Balance Sheet

Concept 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $130.2M
YoY Change -49.82%
Cash & Equivalents $130.2M
Short-Term Investments $0.00
Other Short-Term Assets $35.96M
YoY Change -5.36%
Inventory $155.3M
Prepaid Expenses
Receivables $133.2M
Other Receivables $0.00
Total Short-Term Assets $454.6M
YoY Change -18.8%
LONG-TERM ASSETS
Property, Plant & Equipment $8.798M
YoY Change -5.54%
Goodwill $152.4M
YoY Change 4.02%
Intangibles $6.436M
YoY Change 42806.67%
Long-Term Investments
YoY Change
Other Assets $30.14M
YoY Change -90.29%
Total Long-Term Assets $207.0M
YoY Change -57.39%
TOTAL ASSETS
Total Short-Term Assets $454.6M
Total Long-Term Assets $207.0M
Total Assets $661.6M
YoY Change -36.73%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $155.4M
YoY Change 30.89%
Accrued Expenses $124.3M
YoY Change 3.83%
Deferred Revenue $54.00M
YoY Change 2.86%
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $344.4M
YoY Change 14.5%
LONG-TERM LIABILITIES
Long-Term Debt $93.05M
YoY Change -34.33%
Other Long-Term Liabilities $4.079M
YoY Change 7.37%
Total Long-Term Liabilities $4.079M
YoY Change 7.37%
TOTAL LIABILITIES
Total Short-Term Liabilities $344.4M
Total Long-Term Liabilities $4.079M
Total Liabilities $477.7M
YoY Change -1.83%
SHAREHOLDERS EQUITY
Retained Earnings -$644.4M
YoY Change 161.02%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $193.2M
YoY Change 5.46%
Treasury Stock Shares
Shareholders Equity $183.9M
YoY Change
Total Liabilities & Shareholders Equity $661.6M
YoY Change -36.73%

Cashflow Statement

Concept 2024 Q3
OPERATING ACTIVITIES
Net Income -$8.211M
YoY Change 122.88%
Depreciation, Depletion And Amortization $1.827M
YoY Change 30.5%
Cash From Operating Activities -$2.244M
YoY Change 40.25%
INVESTING ACTIVITIES
Capital Expenditures $1.943M
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities -$1.943M
YoY Change -104.43%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 103.0K
YoY Change -100.95%
NET CHANGE
Cash From Operating Activities -2.244M
Cash From Investing Activities -1.943M
Cash From Financing Activities 103.0K
Net Change In Cash -4.084M
YoY Change -112.97%
FREE CASH FLOW
Cash From Operating Activities -$2.244M
Capital Expenditures $1.943M
Free Cash Flow -$4.187M
YoY Change 161.69%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
GOPRO, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
77-0629474
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
35964000 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
454579000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8798000 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
15738000 usd
CY2024Q3 us-gaap Goodwill
Goodwill
152351000 usd
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
30137000 usd
CY2024Q3 us-gaap Assets
Assets
661603000 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
155387000 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
124299000 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
10737000 usd
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
54002000 usd
CY2024Q3 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
14628000 usd
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
26608000 shares
CY2024Q3 us-gaap Treasury Stock Value
TreasuryStockValue
193231000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-644416000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
183943000 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
661603000 usd
CY2024Q3 us-gaap Revenues
Revenues
258898000 usd
CY2023Q3 us-gaap Revenues
Revenues
294299000 usd
us-gaap Revenues
Revenues
600591000 usd
CY2024Q3 us-gaap Cost Of Revenue
CostOfRevenue
167052000 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
200095000 usd
us-gaap Cost Of Revenue
CostOfRevenue
398997000 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
91846000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
94204000 usd
us-gaap Gross Profit
GrossProfit
201594000 usd
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
44328000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
41708000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
135872000 usd
CY2024Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
40686000 usd
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
41254000 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14843000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15029000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
44470000 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
99857000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
97991000 usd
us-gaap Operating Expenses
OperatingExpenses
297527000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3787000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-95933000 usd
CY2023Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
1963000 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1883000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
792000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2438000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6128000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2995000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-93495000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2083000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
689000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
301625000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-8211000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-3684000 usd
us-gaap Net Income Loss
NetIncomeLoss
-395120000 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.59
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.33
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
153741000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
154113000 shares
us-gaap Net Income Loss
NetIncomeLoss
-395120000 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
296759000 usd
dei Trading Symbol
TradingSymbol
GPRO
dei Entity Central Index Key
EntityCentralIndexKey
0001500435
dei City Area Code
CityAreaCode
(650)
dei Local Phone Number
LocalPhoneNumber
332-7600
dei Security12b Title
Security12bTitle
Class A common stock, $0.0001 par value
dei Trading Symbol
TradingSymbol
GPRO
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
130195000 usd
CY2024Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
0 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
344425000 usd
CY2024Q3 us-gaap Long Term Debt
LongTermDebt
93053000 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
21475000 usd
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4079000 usd
CY2024Q3 us-gaap Liabilities
Liabilities
477660000 usd
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q3 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
1021590000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
117185000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-8011000 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
152409000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
152409000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
152449000 shares
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4711000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
23933000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-29869000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
585150000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
7000 usd
CY2023Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
583000 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11117000 usd
CY2023Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
15000000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-17212000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
563479000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1580000 usd
CY2023Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
2312000 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10017000 usd
CY2023Q3 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
2605000 shares
CY2023Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
10000000 usd
CY2023Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
10000000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-3684000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
559080000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
555846000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1361000 usd
CY2024Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1977000 usd
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8770000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
59100000 usd
CY2023Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
12200000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
50600000 usd
CY2023Q3 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
23100000 usd
dei Entity Address Address Line1
EntityAddressAddressLine1
3025 Clearview Way
dei Entity Address City Or Town
EntityAddressCityOrTown
San Mateo,
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94402
us-gaap Operating Expenses
OperatingExpenses
288573000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-66095000 usd
CY2024Q3 us-gaap Interest Expense
InterestExpense
808000 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
1171000 usd
us-gaap Interest Expense
InterestExpense
2272000 usd
CY2024Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
2691000 usd
CY2024Q3 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
30971000 usd
CY2024Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
124288000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
155259000 usd
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
87780000 usd
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
78982000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8798000 usd
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Security12b Title
Security12bTitle
Class A common stock, $0.0001 par value
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
77-0629474
dei Entity Address Address Line1
EntityAddressAddressLine1
3025 Clearview Way
dei Entity Address City Or Town
EntityAddressCityOrTown
San Mateo,
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94402
dei City Area Code
CityAreaCode
(650)
dei Local Phone Number
LocalPhoneNumber
332-7600
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023Q2 dei Entity Public Float
EntityPublicFloat
522125000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
222708000 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
23867000 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
133161000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
91452000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
106266000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
38298000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
482591000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8686000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
146459000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
311486000 usd
CY2023Q4 us-gaap Assets
Assets
967951000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
102612000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
110049000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
10520000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
55913000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
279094000 usd
CY2023Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
11199000 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
92615000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
25527000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3670000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
412105000 usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
998373000 usd
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
26608000 shares
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
193231000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-249296000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
555846000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
967951000 usd
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2024Q3 us-gaap Inventory Net
InventoryNet
155259000 usd
us-gaap Revenues
Revenues
710039000 usd
us-gaap Cost Of Revenue
CostOfRevenue
487561000 usd
us-gaap Gross Profit
GrossProfit
222478000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
121796000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
119215000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
47562000 usd
us-gaap Interest Expense
InterestExpense
3463000 usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
4710000 usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
7231000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3768000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-62327000 usd
us-gaap Net Income Loss
NetIncomeLoss
-50765000 usd
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.59
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
152449000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
154113000 shares
us-gaap Net Income Loss
NetIncomeLoss
-50765000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5001000 usd
gpro Operating Lease Right Of Use Asset Periodic Reduction Net
OperatingLeaseRightOfUseAssetPeriodicReductionNet
-285000 usd
gpro Operating Lease Right Of Use Asset Periodic Reduction Net
OperatingLeaseRightOfUseAssetPeriodicReductionNet
2133000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
31448000 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-17964000 usd
us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
3276000 usd
us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
0 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-627000 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-1968000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
41746000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
30630000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
48993000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
27745000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4650000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
6895000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
64807000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
25712000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-2107000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-100042000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-76592000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3623000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
985000 usd
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
0 usd
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
25782000 usd
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
24000000 usd
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
134204000 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
12308000 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
8069000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
107437000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2150000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3876000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2847000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
7146000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
30000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-697000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-33270000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
157000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-326000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-92513000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2751000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
223735000 usd
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
130195000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
220984000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
611559000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2397000 usd
CY2023Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
4251000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10314000 usd
CY2023Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
890000 shares
CY2023Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
5000000 usd
CY2023Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
5000000 usd
CY2023Q2 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
3606000 shares
CY2023Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
15000000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-11600000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-62300000 usd
us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
14400000 usd
us-gaap Income Tax Effects Allocated Directly To Equity Other
IncomeTaxEffectsAllocatedDirectlyToEquityOther
2400000 usd
us-gaap Other Tax Expense Benefit
OtherTaxExpenseBenefit
100000 usd
us-gaap Income Tax Reconciliation Nondeductible Expense Restructuring Charges
IncomeTaxReconciliationNondeductibleExpenseRestructuringCharges
300000 usd
CY2024Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
29800000 usd
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
25800000 usd
CY2024Q3 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
14000000.0 usd
CY2024Q3 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
3900000 usd
CY2024Q3 gpro Minimum Effective Tax
MinimumEffectiveTax
15
CY2024Q3 gpro Minimum Effective Tax
MinimumEffectiveTax
15
CY2024Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
2486000 usd
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
2363000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
7792000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
8557000 usd
CY2024Q3 us-gaap Sublease Income
SubleaseIncome
722000 usd
CY2023Q3 us-gaap Sublease Income
SubleaseIncome
277000 usd
us-gaap Sublease Income
SubleaseIncome
2094000 usd
us-gaap Sublease Income
SubleaseIncome
1723000 usd
CY2024Q3 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
0 usd
CY2023Q3 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
0 usd
us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
3276000 usd
us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
0 usd
CY2024Q3 us-gaap Lease Cost
LeaseCost
1764000 usd
CY2023Q3 us-gaap Lease Cost
LeaseCost
2086000 usd
us-gaap Lease Cost
LeaseCost
8974000 usd
us-gaap Lease Cost
LeaseCost
6834000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
10371000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
9526000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
4801000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3047000 usd
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y3M3D
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y18D
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.063
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.062
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
2440000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
13750000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
13270000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2148000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
811000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
3782000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
36201000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
3989000 usd
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
32212000 usd
CY2024Q3 us-gaap Other Commitment
OtherCommitment
224400000 usd
CY2024Q3 us-gaap Financing Receivable Significant Sales
FinancingReceivableSignificantSales
21997000 usd
CY2023Q3 us-gaap Financing Receivable Significant Sales
FinancingReceivableSignificantSales
32011000 usd
us-gaap Financing Receivable Significant Sales
FinancingReceivableSignificantSales
59489000 usd
us-gaap Financing Receivable Significant Sales
FinancingReceivableSignificantSales
73050000 usd
CY2024Q3 us-gaap Gain Loss On Sale Of Accounts Receivable
GainLossOnSaleOfAccountsReceivable
308000 usd
CY2023Q3 us-gaap Gain Loss On Sale Of Accounts Receivable
GainLossOnSaleOfAccountsReceivable
434000 usd
us-gaap Gain Loss On Sale Of Accounts Receivable
GainLossOnSaleOfAccountsReceivable
834000 usd
us-gaap Gain Loss On Sale Of Accounts Receivable
GainLossOnSaleOfAccountsReceivable
1101000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
18729000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-11562000 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.33
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
153741000 shares
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-4919000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
222708000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-339088000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
224912000 usd
CY2024Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
203000 usd
CY2024Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7791000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-47821000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
184679000 usd
CY2024Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
770000 usd
CY2024Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
667000 usd
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7372000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-8211000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
183943000 usd
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:6pt"><span style="color:#009fdf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of estimates. </span><span style="color:#009fdf;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported and disclosed in the Company’s condensed consolidated financial statements and accompanying notes. Significant estimates and assumptions made by management include those related to revenue recognition and the allocation of the transaction price (including sales incentives, sales returns and implied post contract support), inventory valuation, product warranty liabilities, the valuation, impairment and useful lives of long-lived assets (property and equipment, operating lease right-of-use assets, intangible assets and goodwill), fair value of convertible senior notes, and income taxes. The Company bases its estimates and assumptions on historical experience and on various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ materially from management’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations could be affected.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company performs an annual assessment of its goodwill during the fourth quarter of each calendar year or more frequently if indicators of potential impairment exist, such as an adverse change in business climate, declines in market capitalization or a decline in the overall industry demand, that would indicate it is more likely than not that the fair value of its single reporting unit is less than its’ carrying value. If the Company determines that it is more likely than not that the fair value of its single reporting unit is less than the carrying value, the Company measures the amount of impairment as the amount the carrying value of its single reporting unit exceeds the fair value, up to the carrying value of goodwill, by using a discounted cash flow method and market approach method.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the Company’s market capitalization further declined in the third quarter of 2024, the Company does not believe that it is more likely than not that the fair value of its single reporting unit is less than the carrying value. Using the market capitalization approach, which the Company expects would be similar to the discounted cash </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">flow method, the fair value of the single reporting unit is estimated based on the trading price of the Company’s stock at the test date, which is further adjusted by an acquisition control premium representing the synergies a market participant would obtain when obtaining control of the business. As of September 30, 2024, the market capitalization exceeded the carrying value of the single reporting unit by 13% which was not adjusted for an acquisition control premium. The acquisition control premium would further increase the percentage by which the estimated fair value of the Company’s single reporting unit would exceed the carrying value.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of the Company’s single reporting unit is sensitive to the volatility in the Company’s stock price. For example, a 5% decrease in the Company’s September 30, 2024 stock price would result in its market capitalization exceeding the carrying value of its single reporting unit by 8%, which is not adjusted for an acquisition control premium. If the Company's market capitalization continues to decline or future performance falls below the Company’s current expectations, assumptions, or estimates, including assumptions related to current macroeconomic uncertainties, this may trigger a future material non-cash goodwill impairment charge, which could have a material adverse effect on the Company’s business, financial condition, and results of operations in the reporting period in which a charge would be necessary. The Company will continue to monitor developments, including updates to the Company’s forecasts and market capitalization. An update of the Company’s assessment and related estimates may be required in the future.</span></div>
CY2024Q3 us-gaap Reporting Unit Percentage Of Fair Value In Excess Of Carrying Amount
ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount
0.13
CY2024Q3 gpro Market Capitalization Sensitivity
MarketCapitalizationSensitivity
0.08 rate
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
130200000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-644400000 usd
CY2024Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
57000000.0 usd
CY2024Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
11200000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
50600000 usd
CY2024Q3 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
23000000.0 usd
us-gaap Revenue Recognition Incentives
RevenueRecognitionIncentives
<div style="margin-top:6pt"><span style="color:#009fdf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sales incentives.</span><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers sales incentives through various programs, including cooperative advertising, price protection, marketing development funds, and other incentives. Sales incentives are considered to be variable consideration, which the Company estimates and records as a reduction to revenue at the date of sale. The Company estimates sales incentives based on historical experience, product sell-through, and other factors.</span></div>
CY2024Q1 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
294900000 usd
CY2024Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
7500000 usd
CY2024Q1 us-gaap Goodwill
Goodwill
5900000 usd
CY2024Q3 us-gaap Cash
Cash
69900000 usd
CY2023Q4 us-gaap Cash
Cash
69900000 usd
CY2023Q4 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
50000000.0 usd
CY2024Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
1000000.0 usd
CY2023Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
0 usd
CY2023Q4 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
20311000 usd
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
85955000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
106266000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
88126000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
79440000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8686000 usd
CY2024Q3 gpro Pointof Purchase Pop Displays
PointofPurchasePOPDisplays
14853000 usd
CY2023Q4 gpro Pointof Purchase Pop Displays
PointofPurchasePOPDisplays
6254000 usd
CY2024Q3 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
8122000 usd
CY2023Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
8233000 usd
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
6421000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
15000 usd
CY2024Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
741000 usd
CY2023Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
296984000 usd
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
30137000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
311486000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
58566000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
52160000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6406000 usd
CY2024Q3 us-gaap Indefinite Lived Trademarks
IndefiniteLivedTrademarks
15000 usd
CY2024Q3 us-gaap Indefinite Lived Trademarks
IndefiniteLivedTrademarks
15000 usd
CY2024Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
58581000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
52160000 usd
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
6421000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
51066000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
51066000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
0 usd
CY2023Q4 us-gaap Indefinite Lived Trademarks
IndefiniteLivedTrademarks
15000 usd
CY2023Q4 us-gaap Indefinite Lived Trademarks
IndefiniteLivedTrademarks
15000 usd
CY2023Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
51081000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
51066000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
15000 usd
CY2024Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
7500000 usd
CY2024Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
500000 usd
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1100000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
468000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1875000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1875000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1875000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1875000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
313000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6406000 usd
CY2024Q3 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
53668000 usd
CY2023Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
42752000 usd
CY2024Q3 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
30792000 usd
CY2023Q4 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
21214000 usd
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5846000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
18969000 usd
CY2024Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
6801000 usd
CY2023Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
8270000 usd
CY2024Q3 us-gaap Customer Refund Liability Current
CustomerRefundLiabilityCurrent
6102000 usd
CY2023Q4 us-gaap Customer Refund Liability Current
CustomerRefundLiabilityCurrent
6389000 usd
CY2024Q3 gpro Accrued Inventory
AccruedInventory
8944000 usd
CY2023Q4 gpro Accrued Inventory
AccruedInventory
1745000 usd
CY2024Q3 us-gaap Deposits
Deposits
2458000 usd
CY2023Q4 us-gaap Deposits
Deposits
1933000 usd
CY2024Q3 us-gaap Purchase Commitment Remaining Minimum Amount Committed
PurchaseCommitmentRemainingMinimumAmountCommitted
1619000 usd
CY2023Q4 us-gaap Purchase Commitment Remaining Minimum Amount Committed
PurchaseCommitmentRemainingMinimumAmountCommitted
899000 usd
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
8069000 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
7878000 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
124299000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
110049000 usd
CY2024Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
6520000 usd
CY2023Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
7304000 usd
CY2023Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
8759000 usd
CY2022Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
8319000 usd
CY2024Q3 us-gaap Product Warranty Expense
ProductWarrantyExpense
4234000 usd
CY2023Q3 us-gaap Product Warranty Expense
ProductWarrantyExpense
6284000 usd
us-gaap Product Warranty Expense
ProductWarrantyExpense
8573000 usd
us-gaap Product Warranty Expense
ProductWarrantyExpense
14758000 usd
CY2024Q3 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
3385000 usd
CY2023Q3 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
5392000 usd
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
9963000 usd
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
14881000 usd
CY2024Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
7369000 usd
CY2023Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
8196000 usd
CY2024Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
7369000 usd
CY2023Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
8196000 usd
CY2024Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
6800000 usd
CY2023Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
8300000 usd
CY2024Q3 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
600000 usd
CY2023Q4 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
500000 usd
CY2021Q1 gpro Debt Instrument Covenant Compliance Asset Coverage Ratio
DebtInstrumentCovenantComplianceAssetCoverageRatio
1.50
CY2024Q3 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
5200000 usd
CY2020Q4 gpro Adjustments To Additional Paid In Capital Purchase Of Capped Call Transactions
AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactions
10200000 usd
CY2020Q4 gpro Option Indexed To Issuers Equity Cap Price
OptionIndexedToIssuersEquityCapPrice
12.0925 usd
CY2023Q4 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
50000000.0 usd
CY2023Q4 us-gaap Debt Instrument Repurchase Amount
DebtInstrumentRepurchaseAmount
46300000 usd
CY2023Q4 us-gaap Debt Instrument Repurchased Face Amount
DebtInstrumentRepurchasedFaceAmount
49400000 usd
CY2023Q4 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
3100000 usd
CY2022Q1 srt Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
100 usd
CY2023Q1 srt Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
40 usd
CY2024Q3 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
60400000 usd
CY2024Q3 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0 shares
CY2023Q3 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
2605 shares
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0 shares
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
7101 shares
CY2024Q3 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
0
CY2023Q3 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
3.84
us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
0
us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
4.22
CY2024Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
0 usd
CY2023Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
10000000 usd
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
0 usd
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
30000000 usd
CY2024Q3 us-gaap Revenues
Revenues
258898000 usd
CY2023Q3 us-gaap Revenues
Revenues
294299000 usd
us-gaap Revenues
Revenues
600591000 usd
us-gaap Revenues
Revenues
710039000 usd
CY2024Q3 us-gaap Restructuring Charges
RestructuringCharges
1382000 usd
CY2023Q3 us-gaap Restructuring Charges
RestructuringCharges
0 usd
us-gaap Restructuring Charges
RestructuringCharges
6642000 usd
us-gaap Restructuring Charges
RestructuringCharges
-164000 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2684000 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.43
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y29D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
357000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
14.96
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2327000 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.43
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y10M2D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
2327000 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
7.43
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P4Y10M2D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
0 usd
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2015000 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
7.75
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y3M14D
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 usd
us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
1400000 shares
us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
900000 shares
us-gaap Employee Stock Ownership Plan Esop Weighted Average Purchase Price Of Shares Purchased
EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased
1.56
us-gaap Employee Stock Ownership Plan Esop Weighted Average Purchase Price Of Shares Purchased
EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased
4.10
CY2024Q3 us-gaap Share Based Compensation
ShareBasedCompensation
7372000 usd
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
10017000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
23933000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
31448000 usd
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0 usd
CY2023Q3 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
2300000 usd
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
7100000 usd
CY2024Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y3M21D
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-8211000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-3684000 usd
us-gaap Net Income Loss
NetIncomeLoss
-395120000 usd
us-gaap Net Income Loss
NetIncomeLoss
-50765000 usd
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
153741000 shares
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
153741000 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
152409000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
152409000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
152449000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
152449000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
154113000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
154113000 shares
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.59
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.59
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.33
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.33
CY2024Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
27006000 shares
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
30945000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
26654000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
30820000 shares
gpro Conversion Of Stock Maxium Percent Of Outstanding Shares In Class Of Total Outstanding Shares
ConversionOfStockMaxiumPercentOfOutstandingSharesInClassOfTotalOutstandingShares
0.10
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2083000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
689000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
301625000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-11562000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2100000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6100000 usd
CY2024Q3 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
2100000 usd
CY2024Q3 us-gaap Income Tax Effects Allocated Directly To Equity Other
IncomeTaxEffectsAllocatedDirectlyToEquityOther
1900000 usd
CY2024Q3 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-1600000 usd
CY2024Q3 us-gaap Income Tax Reconciliation Nondeductible Expense Restructuring Charges
IncomeTaxReconciliationNondeductibleExpenseRestructuringCharges
300000 usd
CY2024Q3 us-gaap Other Tax Expense Benefit
OtherTaxExpenseBenefit
100000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
301600000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-93500000 usd
us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
5000000.0 usd
us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
293400000 usd
us-gaap Income Tax Effects Allocated Directly To Equity Other
IncomeTaxEffectsAllocatedDirectlyToEquityOther
4900000 usd
us-gaap Income Tax Reconciliation Nondeductible Expense Restructuring Charges
IncomeTaxReconciliationNondeductibleExpenseRestructuringCharges
1300000 usd
us-gaap Other Tax Expense Benefit
OtherTaxExpenseBenefit
500000 usd
CY2024Q1 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
294900000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
700000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3000000 usd
CY2023Q3 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
1000000.0 usd
CY2023Q3 us-gaap Income Tax Effects Allocated Directly To Equity Other
IncomeTaxEffectsAllocatedDirectlyToEquityOther
1700000 usd
CY2023Q3 us-gaap Income Tax Reconciliation Nondeductible Expense Restructuring Charges
IncomeTaxReconciliationNondeductibleExpenseRestructuringCharges
100000 usd
CY2023Q3 us-gaap Other Tax Expense Benefit
OtherTaxExpenseBenefit
100000 usd

Files In Submission

Name View Source Status
0001500435-24-000154-index-headers.html Edgar Link pending
0001500435-24-000154-index.html Edgar Link pending
0001500435-24-000154.txt Edgar Link pending
0001500435-24-000154-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
gpro-20240930.htm Edgar Link pending
gpro-20240930.xsd Edgar Link pending
gpro-20240930_g1.jpg Edgar Link pending
gpro2024-09x30exhibit3101.htm Edgar Link pending
gpro2024-09x30exhibit3102.htm Edgar Link pending
gpro2024-09x30exhibit3201.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
gpro-20240930_cal.xml Edgar Link unprocessable
gpro-20240930_lab.xml Edgar Link unprocessable
gpro-20240930_pre.xml Edgar Link unprocessable
gpro-20240930_htm.xml Edgar Link completed
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
gpro-20240930_def.xml Edgar Link unprocessable